NewsRx

Search our medical news database

Can-Fite BioPharma

Ilan Cohn named vice chairman of the board at Israeli pharmaceutical firm

Published in Medical Verdicts and Law Weekly, March 9th, 2006

Can-Fite BioPharma (TASE:CFBI) announced that Ilan Cohn, a member the of board of directors, was appointed by the board of directors as Vice chairman of the board.

Ilan Cohn, who was the founder and seed investor in Can Fite BioPharma, is a Senior Partner in Reinhold Cohn and Partners, Israel's largest intellectual property firm. Cohn is one of the leading patent attorneys in Israel, with particular expertise in the life sciences field. Cohn has a PhD in biology from the Hebrew University of Jerusalem.

Throughout his professional career he gained extensive experience and expertise in business development in the biotechnology field and build-up of...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook